Clinical Trials Logo

Clinical Trial Summary

The aim of this study was to determine and compare the clinical efficacy of VT and STT alone or in combination for the patients with temporo-mandibular joint (TMJ) osteoarthritis.


Clinical Trial Description

Study design and patients´ selection: This prospective parallel randomized clinical trial included patients diagnosed with TMJ osteoarthritis. All Patients were collected from the TMD clinic of Prosthodontics Department, Faculty of Dentistry, Mansoura University. The study was approved by the local ethics committee with ethical approval number A12060922. All patients were aware of the treatment procedures and signed informed consents for their participation. Patients were recruited and data collection was performed between . CONSORT guidelines were followed when approperiate19 Inclusion and exclusion criteria were defined prior to the beginning of the study. Inclusion criteria were: (I) clinical diagnosis of TMJ osteoatrhritis according to diagnostic criteria involved in the DC/TMD axis I group 3.A.2 item20 including self-report of TMJ pain, tenderness to palpation, and crepitus (II) magnetic resonance imaging (MRI)signs of joint effusion, erosions and ⁄ or sclerosis of the cortical outline, flattening of the joint surfaces and ⁄ or osteophyte formation ; and (III) age cognitively capable of understanding the standardized questionnaire. Exclusion criteria were: (I) Patients with systemic disease affecting the joints (II) previous TMJ treatment, (III) previous trauma to TMJ or to the jaws, and (IV) edentulous patients, (V) use of anti-inflammatory drugs at least one month before assessment and during the treatment period. Sample size calculation: Sample size calculation was performed by using G*Power software (version 3.1.9.7) based on previous study by El-Shaheed et al.21 A medium effect size (f = 0.25) for interaction effect of treatment group and time on quantitative outcomes (amount of mouth opening in mm, temporo-mandibular joint palpation and VAS score for pain) and a large effect size (f = 0.4) for main group effect on these outcome measures were hypothesised. Based on these assumptions, a total sample size of 42 (14 in each treatment group) achieved 83% power to detect a large effect size (f = 0.4) with 0.05 α-error probability using F test anova: Repeated measures, between factors for three groups and five measurements with a .5 correlation between measurements. Patients' randomization: Patients who are eligible in this study after screening phase and who agree to sign the consent form were randomly assigned to grouping. Patient's randomization was performed by two assistants who did not participate in the trial. One assistant had prepared sequentially numbered sealed envelopes with random assignment. The assignment of the treatment was then completed by another assistant from outside the trial. Patients whose treatment plans included vacuum therapy (VT) were designated group (I) and included 14 patients, and those with stabilization splint therapy (SST) were designated (group (II) and included 14 patients. Patients whose treatment plans included both vacuum therapy and splint therapy (VT + SST) were designated as group (III) and included 14 patients. Intervention: The treatments were applied by an experienced dentist, with the necessary training in TMD specialty. For group (I) (VT group), vacuum therapy was applied over the TMJ. Before intervention, all patients were informed about initial suction sensation and possible appearance of bruising at the application site. Basic vacuum therapy equipment (cangexia, China) was utilized including a manual suction pump, plastic cups of 40 mm diameter with rolled edge, and anti-septic tools. The cup can be fixed by means of fixation gel () before application of the cup as hair might interfere with the cup peripheral seal. Dry vacuum therapy was accomplished by application of constant negative pressure of 300 mbar (which is equal to two suctions) using the manual suction pump through the suction cup over the TMJ region for 5 minutes22 (Fig.1). Whether any extra oral muscle showed pain, vacuum therapy application was performed using the same protocol. After completing the procedures, an anti-septic solution was placed over the vacuum application site (sites). All patients in this group were treated one session per week for four successive weeks (Fig.2). For group (II) (ST group), A maxillary stabilization splint (MSS) was constructed for each patient from hard, heat-cured clear acrylic resin and fitted to the maxillary teeth. On the mounted master casts, the vertical dimension was adjusted to provide 3 mm of vertical space between the closest opposing cusps of the maxillary and mandibular teeth. The occlusal contact of the splint was adjusted to provide even simultaneous contact with the opposing mandibular cusps in the treatment position. the mandibular canines provide laterotrusive guidance in lateral exertions (canine guidance), and mandibular anterior teeth provide anterior contact and posterior disocclusion (anterior guidance). After processing, the splint was fitted on the maxillary arch and adjusted if needed (Fig.3). Patients were advised to wear it 12 hours per day for six months. Patients were recalled regularly for occlusal readjustment of the splint. For group (III) (VT+SST), both VT and SST were started at the same day. Procedures were the same as in group I and II. Collagen hydrolysate Patients' evaluation: Patients' evaluation was performed by an experienced independent researcher who did not participate in other procedures in this study and was blinded to all intervention groups. I- Clinical evaluation: Patients were evaluated regarding their TMJ signs and symptoms at base line (T0), one week (Tw), one month (T1), three months (T3), and six months (T6): 1. Maximum comfortable mouth opening (MCO) was measured using millimeter ruler between the incisal edges plus the overbite while the patient opens at maximum comfortable opening. 2. The degree of pain was evaluated using 0 to10 mm Visual Analogue Scale (VAS) for pain (where 0 equals no pain and 10 is the most severe pain). 3. TMJ tenderness on palpation was assessed by Verbal Rating Scale (VRS) using firm and constant pressure of half kg lasted two seconds over the condyle in front of the tragus. The degree of joint tenderness was extended from 0 to 3 (0: no; 1: slight; 2: moderate; 3: severe). 4. Joint sound was detected using stethoscope 5. Change perception was assessed at Tw, T1, T3, and T6 with the Patient Global Impression of Change Scale (PGICS) which evaluates the change perceived by the patients after treatment. This scale has seven affirmations depicting a patient's rating of overall improvement (1 "very much improved", 2 "much improved", 3 "minimally improved", 4 "no change", 5 "minimally worse", 6 "much worse", or 7 "very much worse"). 6. Any side effects from either treatments also had been reported. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06228612
Study type Interventional
Source Mansoura University
Contact
Status Completed
Phase N/A
Start date January 20, 2021
Completion date November 17, 2023

See also
  Status Clinical Trial Phase
Completed NCT04657926 - A Trial of APPA in the Treatment of Knee Osteoarthritis Phase 2
Completed NCT02536833 - A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects Phase 2
Completed NCT03014037 - Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration N/A
Recruiting NCT05937542 - A Qualitative Investigation of CLEAT Participants
Completed NCT03644615 - A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT03850665 - Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach N/A
Completed NCT02826902 - Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial N/A
Completed NCT04402502 - Dynamic 4DCT to Examine Wrist Carpal Mechanics N/A
Completed NCT02923700 - Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial Phase 4
Completed NCT04564053 - Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants Phase 1
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT05036174 - Diphenhydramine Ointment for Knee Osteoarthritis N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A
Recruiting NCT02912429 - Onlay vs. Inlay Patellofemoral Arthroplasty N/A
Active, not recruiting NCT02723929 - Effects of tDCS and tUS on Pain Perception in OA of the Knee
Withdrawn NCT02921594 - Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties N/A
Terminated NCT02820766 - Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting N/A